Skip to content
SC Injection Allopathic

Forteo 20 mcg/80 mcl sc injection

Generic: Teriparatide

Company: Not listed yet. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength20 mcg/80 mcl
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated September 7, 2024.

Compare

Same generic, same strength

Sorted by price per sc injection. Ask your pharmacist before you switch brands.

Teriparatide 20 mcg/80 mcl sc injections

Prices as listed on BestinMeds.

No price is listed for this strength yet.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Teriparatide guide

Indications

Osteoporosis Teriparatide is a parathyroid hormone analog, (PTH 1-34), indicated for: Treatment of postmenopausal women with osteoporosis at high risk for fracture. Increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture. Treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy at high risk for fracture.

Dosage and administration

Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture: The recommended dose is 20 mcg subcutaneously once a day. Increase of Bone Mass in Men with Primary or Hypogonadal Osteoporosis at High Risk for Fracture: The recommended dose is 20 mcg subcutaneously once a day. Treatment of Men and Women with Glucocorticoid-Induced Osteoporosis at High Risk for Fracture: The recommended dose is 20 mcg subcutaneously once a day.

Side effects

Most common adverse reactions include: arthralgia, pain, and nausea.

Precautions and warnings

Patients with Paget’s disease of bone, pediatric and young adult patients with open epiphyses, and patients with prior external beam or implant radiation involving the skeleton: Should not be treated with Teriparatide Treatment duration: Use of Teriparatide for more than 2 years during a patient’s lifetime is not recommended. Patients with bone metastases, history of skeletal malignancies, metabolic bone diseases other than osteoporosis, or hypercalcemic disorders: Should not be treated with Teriparatide Laboratory alterations: Teriparatide may increase serum calcium, urinary calcium, and serum uric acid Urolithiasis: Use with caution in patients with active or recent urolithiasis because of risk of exacerbation Orthostatic hypotension: Transient orthostatic hypotension may occur with initial doses of Teriparatide.

Pregnancy and lactation

There are no available data on Teriparatide use in pregnant women to evaluate for drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Consider discontinuing Teriparatide when pregnancy is recognized. It is not known whether teriparatide is excreted in human milk, affects human milk production, or has effects on the breastfed infant.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250